subtee: An R Package for Subgroup Treatment Effect Estimation in Clinical Trials

The investigation of subgroups is an integral part of randomized clinical trials. Exploration of treatment effect heterogeneity is typically performed by covariate-adjusted analyses including treatment-by-covariate interactions. Several statistical techniques, such as model averaging and bagging, were proposed recently to address the problem of selection bias in treatment effect estimates for subgroups. In this paper, we describe the subtee R package for subgroup treatment effect estimation. The package can be used for all commonly encountered type of outcomes in clinical trials (continuous, binary, survival, count). We also provide additional functions to build the subgroup variables to be used and to plot the results using forest plots. The functions are demonstrated using data from a clinical trial investigating a treatment for prostate cancer with a survival endpoint.

[1]  G. Rosenkranz.  Exploratory Subgroup Analyses in Clinical Research , 2019 .

[2]  Marius Thomas,et al.  Comparing Approaches to Treatment Effect Estimation for Subgroups in Clinical Trials , 2016 .

[3]  A. Raftery.  Bayesian Model Selection in Social Research , 1995 .

[4]  R. Simon,et al.  Bayesian subset analysis. , 1991, Biometrics.

[5]  A. Dreher.  Modeling Survival Data Extending The Cox Model , 2016 .

[6]  D.,et al.  Regression Models and Life-Tables , 2022 .

[7]  Gerd K. Rosenkranz.  Bootstrap corrections of treatment effect estimates following selection , 2014, Comput. Stat. Data Anal..

[8]  Achim Zeileis,et al.  model4you: An R Package for Personalised Treatment Effect Estimation , 2019 .

[9]  Gerd K Rosenkranz,et al.  Exploratory subgroup analysis in clinical trials by model selection , 2016, Biometrical journal. Biometrische Zeitschrift.

[10]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[11]  I. Lipkovich,et al.  Subgroup identification based on differential effect search—A recursive partitioning method for establishing response to treatment in patient subpopulations , 2011, Statistics in medicine.

[12]  B. Efron.  Estimation and Accuracy After Model Selection , 2014, Journal of the American Statistical Association.

[13]  J. M. Taylor,et al.  Subgroup identification from randomized clinical trial data , 2011, Statistics in medicine.

[14]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[15]  Achim Zeileis,et al.  Model-Based Recursive Partitioning for Subgroup Analyses , 2016, The international journal of biostatistics.

[16]  V. Devanarayan,et al.  Patient subgroup identification for clinical drug development , 2017, Statistics in medicine.

[17]  Bradley P. Carlin,et al.  credsubs: Multiplicity-Adjusted Subset Identification , 2020, Journal of Statistical Software.

[18]  Guideline on the investigation of subgroups in confirmatory clinical trials , 2014 .

[19]  R. Varadhan,et al.  Treatment effect heterogeneity for univariate subgroups in clinical trials: Shrinkage, standardization, or else , 2016, Biometrical journal. Biometrische Zeitschrift.

[20]  Thomas A. Louis,et al.  Beanz: An R package for Bayesian analysis of heterogeneous treatment effects with a graphical user interface , 2018 .

[21]  Tianxi Cai,et al.  A general statistical framework for subgroup identification and comparative treatment scoring , 2017, Biometrics.

[22]  Stephen J. Ruberg,et al.  Personalized Medicine: Four Perspectives of Tailored Medicine , 2015 .

[23]  Bohdana Ratitch,et al.  Multiplicity issues in exploratory subgroup analysis , 2018, Journal of biopharmaceutical statistics.

[24]  Heinz Schmidli,et al.  Model averaging for treatment effect estimation in subgroups , 2017, Pharmaceutical statistics.

[25]  Trevor J. Hastie,et al.  Confidence intervals for random forests: the jackknife and the infinitesimal jackknife , 2013, J. Mach. Learn. Res..